SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Form 8 (DD) - Xploite PLC

23 Apr 2010 16:55

RNS Number : 7350K
Xploite PLC
23 April 2010
 



FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer or person acting in concert making the disclosure:

Tony Weaver (Chief Operating Officer)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xploite plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Offeree

(e) Date dealing undertaken:

23/04/10

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

860,785

3.7%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

860,785

3.7%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Ordinary shares

Exercise of Options over new shares

 

344,828

29p

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

23 April 2010

Contact name:

Tony Weaver

Telephone number:

+44 (0) 870 737 2001

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCBUGDSSUDBGGX
Date   Source Headline
7th Jan 20081:37 pmRNSResult of EGM
27th Dec 20078:39 amRNSAssignment of Lease
21st Dec 20073:49 pmRNSPosting of Circular
20th Dec 20074:23 pmRNSConditional disposal
29th Nov 20078:00 amRNSFirst Day of Trading
29th Nov 20077:00 amRNSInterims & Proposed Disposal
12th Sep 20077:01 amRNSTrading Statement
13th Aug 20077:00 amRNSAIM Rule 26
30th Jul 20072:03 pmRNSAGM and Directorate Change
26th Jul 20077:00 amRNSProduct Launch
20th Jul 20077:00 amPRNRe Agreement
26th Jun 20071:17 pmRNSStmnt re Share Price Movement
11th Jun 20077:00 amPRNFinal Results
3rd Apr 200711:17 amRNSHolding(s) in Company
19th Mar 20077:01 amRNSTrading Statement
1st Mar 20079:42 amRNSTotal Voting Rights
21st Feb 20077:00 amRNSChange of Registered Address
20th Feb 20076:27 pmRNSDirector/PDMR Shareholding
2nd Feb 20077:00 amRNSRe Agreement
30th Jan 20072:53 pmRNSDirector/PDMR Shareholding
30th Jan 200712:00 pmRNSTrading Statement
21st Dec 20062:51 pmRNSTotal Voting Rights
20th Dec 20063:54 pmRNSDirector/PDMR Shareholding
20th Dec 20063:45 pmRNSDirector/PDMR Shareholding
19th Dec 20067:01 amRNSDirector/PDMR Shareholding
18th Dec 20065:23 pmRNSDirector/PDMR Shareholding
18th Dec 20065:18 pmRNSDirector/PDMR Shareholding
15th Dec 20061:12 pmRNSResult of EGM
30th Nov 20066:15 pmRNSNotification of Interest
29th Nov 20068:40 amRNSIssue of Equity
27th Nov 200612:43 pmRNSStmnt re Share Price Movement
22nd Nov 20065:45 pmRNSIssue of Equity
22nd Nov 20065:39 pmRNSCirc re. Acquistion
21st Nov 20067:01 amRNSInterim Results
11th Sep 20061:50 pmRNSFurther re Product Agreements
4th Sep 20061:18 pmRNSDirectorate Change
14th Jul 20061:47 pmRNSDirector's Dealings
13th Jul 20065:01 pmRNSNotifiable Interest
5th Jul 200611:52 amRNSResult of AGM
4th Jul 20067:00 amRNSDirectorate Change
12th Jun 20067:02 amRNSFurther re Product Launch
8th Jun 20067:02 amRNSRe Agreement
31st May 20067:03 amRNSFinal Results
31st May 20067:03 amRNSDirectorate Change
31st May 20067:03 amRNSChange of Adviser
31st Mar 20067:03 amRNSProduct Launch
30th Mar 20068:16 amRNSTrading Statement
8th Mar 20067:02 amRNSProduct Launch
2nd Mar 200610:07 amRNSDirector/PDMR Shareholding
7th Feb 20067:05 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.